Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Am Heart J. 2019 Jun 28;215:167–177. doi: 10.1016/j.ahj.2019.06.014

Table III.

Baseline Patient Characteristics based on Type of Revascularization.

Multivessel PCI
N=256,865
Hybrid PCI/CABG
N=1,126
p-value
Demographics
 Age (years) 66 (58–75) 65 (58–72) <0.001
 Female 32.0% 29.6% 0.08
 Non-white race 14.1% 14.8% 0.47
 Uninsured 4.5% 7.3% <0.001
History and Risk Factors
 BMI 29.1 (25.7–33.3) 29.0 (25.8–33.1) 0.95
 Prior MI 29.0% 25.9% 0.02
 Previous PCI 38.9% 25.7% <0.001
 Diabetes 41.2% 41.5% 0.87
 Cerebrovascular disease 13.3% 14.0% 0.45
 Hypertension 85.4% 84.2% 0.23
 Dyslipidemia 81.6% 80.0% 0.002
 Creatinine clearance (mL/min) 65.0 (46.4–84.8) 68.4 (49.6–87.0) 0.002
Presentation
 ACS: NSTEMI 26.0% 42.9% <0.001
 ACS: Unstable Angina 45.7% 40.0%
 Stable Angina 17.6% 8.7%
 Atypical Chest Pain 2.7% 1.1%
 No Angina 8.0% 7.4%
 Cardiac arrest* 0.4% 1.4% <0.001
 Ejection Fraction <40% 11.7% 12.3% 0.45
 LM or Prox LAD Lesion 42.9% 69.8% <0.001
 3VD (vs. 2VD) 31.6% 60.0% <0.001
PCI Complexity
 Number of lesions treated 2.0
(2.0, 3.0)
1.0
(1.0, 2.0)
<0.001
 Lesion length 16.0 (12.0–24.0) 18.0 (12.0–26.0) 0.007
 CTO 36.3% 11.9% <0.001
 Pre-procedure TIMI 0/1 13.2% 32.2% <0.001
 High/Type C lesion 50.8% 58.1% <0.001
 Bifurcation lesion 11.6% 9.9% 0.09
 Drug-eluting stent 89.9% 67.1% <0.001
Discharge P2Y12 inhibitor
 Overall 98.0% 83.1% <0.001
 Clopidogrel 73.1% 78.1% <0.001
 Prasugrel 15.4% 2.7% <0.001
 Ticagrelor 10.2% 6.3% <0.001

BMI: Body Mass Index

MI: Myocardial Infarction

PCI: Percutaneous Coronary Intervention

ACS: Acute Coronary Syndrome

LM: Left Main

LAD: Left Anterior Descending

IABP: Intra-aortic Balloon Pump

*

Cardiac arrest within 24 hours of presentation to cardiac catheterization lab

Missing data excluded; all fields with <1% missing data with exception of LM/LAD stenosis